Visual Outcomes and Prognostic Factors after Pars Plana Vitrectomy for Traumatic Endophthalmitis

Table 2

Presentation features associated with better BCVA.

Factor	Number	Improved BCVA (%)	value
Gender ()
Male	103	98/103 (95.15)	0.1781
Female	18	15/18 (83.3)
Treatment period ()
<12 hrs	111	109/111 (98.20)	0.0000
>12 hrs	10	4/10 (40)
PPV period ()
<24 hrs	105	103/105 (98.10)	0.0000
>24 hrs	16	10/16 (62.5)
Laceration length ()
⩽10 mm	110	106/110 (96.36)	0.0004
>10 mm	11	7/11 (63.63)
Presenting VA ()
⩾LP	114	110/114 (96.49)	0.0000
<LP	7	3/7 (42.86)
IOFB
Yes	53	48/53 (90.57)	0.4627
No	68	65/68 (95.59)
Retinal detachment
Yes	37	33/37 (89.19)	0.4028
No	84	80/84 (95.24)
Corneal perforation
Yes	85	82/85 (96.47)	0.0898
No	36	31/36 (86.11)
Scleral perforation
Yes	36	31/36 (86.11)	0.0898
No	85	82/85 (96.47)
SO use
Yes	98	91/98 (92.86)	0.9846
No	23	22/23 (95.65)
Lensectomy
Yes	116	109/116 (93.97)	0.7555
No	5	4/5 (80)

PPV: pars plana vitrectomy; IOFB: intraocular foreign body; SO: silicone oil.